Frontiers in molecular biosciences

How damaged cell cleanup and inflammation interact in turning sudden kidney injury into long-term kidney disease

Updated

Abstract

Essence

and activity may be linked drivers of acute kidney injury progression to chronic kidney disease.

Evidence

This review synthesizes mechanistic AKI-to-CKD literature on NLRP3-mediated inflammation and pyroptosis, mitophagy-mediated mitochondrial clearance, renal tubular injury, chronic inflammation, and fibrosis.

Caveat

The proposed therapeutic strategy is based on mechanistic synthesis rather than direct evidence that targeting NLRP3 or mitophagy prevents AKI-to-CKD transition in patients.

Simplified

Key figures

FIGURE 1
Molecular interactions between and in kidney tubular epithelial cells
Highlights how mitophagy pathways inhibit inflammasome activation and reduce profibrotic signals in kidney cells.
fmolb-12-1643829-g001
  • Single panel
    Shows the two-step activation of NLRP3 inflammasome by , , and mitochondrial damage, leading to and fibrosis signals; mitophagy pathways involving PINK1-Parkin, BNIP3, NIX, FUNDC1, and mitochondrial dynamics modulate inflammasome activity and fibrosis progression.
FIGURE 2
Mitochondrial interactions that activate the in cellular stress.
Highlights how mitochondrial damage and calcium overload visibly enhance NLRP3 inflammasome activation pathways.
fmolb-12-1643829-g002
  • Panel 1
    Mitochondrial damage causes calcium overload via and , triggering release and overproduction.
  • Panel 2
    Inactive NLRP3 binds to mitochondria through , cardiolipin, and , then damaged mitochondria move to the endoplasmic reticulum via microtubules.
  • Panel 3
    NLRP3 moves to mitochondria, then to the Golgi apparatus where the trans-Golgi network disperses () and recruits NLRP3 to form speckles activating oligomerization.
  • Panel 4
    Golgi apparatus recruits mitochondria-associated ER membranes (MAMs) through signaling, promoting further NLRP3 inflammasome activation.
1 / 2

Full Text

What this is

  • This review examines the relationship between acute kidney injury (AKI) and chronic kidney disease (CKD), focusing on the roles of and the .
  • It highlights how these two pathways interact during the transition from AKI to CKD, emphasizing their potential as therapeutic targets.
  • The review discusses various molecular mechanisms and the implications for developing strategies to prevent CKD progression.

Essence

  • and the interact critically in the transition from AKI to CKD. Targeting these pathways may offer new therapeutic strategies to prevent CKD.

Key takeaways

  • activation contributes to the progression from AKI to CKD by promoting inflammation and fibrosis. can suppress NLRP3 activation, providing a protective effect.
  • Impaired leads to mitochondrial dysfunction, exacerbating renal injury and accelerating the transition to CKD. Enhancing may mitigate these effects.
  • Therapeutic strategies targeting the -NLRP3 axis show promise in preclinical models, indicating potential for clinical applications in kidney disease management.

Caveats

  • Current understanding of the -NLRP3 interaction is incomplete, and the dual role of complicates therapeutic approaches.
  • Many NLRP3 inhibitors are still in preclinical stages, and their clinical efficacy remains to be established.
  • Existing animal models do not fully replicate the complexity of human kidney diseases, limiting the translational potential of findings.

Definitions

  • mitophagy: Selective autophagy process that removes damaged mitochondria to maintain cellular health.
  • NLRP3 inflammasome: A protein complex that activates inflammatory responses in response to cellular stress and damage.

Simplified

Funding

Competing interests

No commercial or financial ties reported.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free